Effect of polaprezinc on impaired healing of chronic gastric ulcers in adjuvant-induced arthritic rats - Role of insulin-like growth factors (IGF)-1

Shinichi Kato, Akiko Tanaka, Yoshihiro Ogawa, Kenji Kanatsu, Koichi Seto, Tomoyuki Yoneda, Koji Takeuchi

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Polaprezinc, N-(3-aminopropionyl)-L-histidinatozinc, has been shown to stimulate the production of insulin-like growth factor-1 (IGF-1) in mesenchymal cells, the polypeptide playing a role in the gastric epithelial wound repair. The present study was performed to examine the effect of polaprezinc on the impaired healing of chronic gastric ulcers in adjuvant-induced arthritic rats, in relation to IGF-1. Arthritis was induced in male Dark Agouti (DA) rats by a single injection of Freund's complete adjuvant (FCA), and the gastric ulcers were induced by thermal cauterization (70°C for 30 sec) 7 days after FCA injection. Omeprazole (30 mg/kg) was administered p.o. once daily, while recombinant human IGF-1 (rhIGF-1) (30 μg/kg, s.c.) or polaprezinc (3-10 mg/kg, p.o.) was administered twice daily, starting from 3 days after ulceration for 14 days. The healing of gastric ulcers was significantly delayed in arthritic rats as compared to normal rats on day 10 and 17 following ulceration. The expression of IGF-1 mRNA was markedly increased in the ulcerated mucosa, but this response was apparently attenuated in arthritic rats. Repeated administration of polaprezinc accelerated the healing of gastric ulcers in both normal and arthritic rats, in a dose-dependent manner, and this effect was more pronounced in arthritic rats. Likewise, treatment with omeprazole also significantly promoted the healing of gastric ulcers in both normal and arthritic rats. On the other hand, rhIGF-1 significantly promoted the gastric ulcer healing in arthritic rats Without any effect on that in normal rats. These results suggest that the impaired healing of chronic gastric ulcers in arthritic rats is, at least partly, accounted for by less expression of IGF-1, and the polaprezinc improves the delayed healing of gastric ulcers in arthritic rats, probably through an increase in IGF-1 production.

Original languageEnglish
Pages (from-to)20-25
Number of pages6
JournalMedical Science Monitor
Volume7
Issue number1
Publication statusPublished - Feb 19 2001
Externally publishedYes

Fingerprint

polaprezinc
Experimental Arthritis
Stomach Ulcer
Arthritis
Somatomedins
Omeprazole
Freund's Adjuvant
rat insulin-like growth factor-1
Cautery

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Effect of polaprezinc on impaired healing of chronic gastric ulcers in adjuvant-induced arthritic rats - Role of insulin-like growth factors (IGF)-1. / Kato, Shinichi; Tanaka, Akiko; Ogawa, Yoshihiro; Kanatsu, Kenji; Seto, Koichi; Yoneda, Tomoyuki; Takeuchi, Koji.

In: Medical Science Monitor, Vol. 7, No. 1, 19.02.2001, p. 20-25.

Research output: Contribution to journalArticle

Kato, Shinichi ; Tanaka, Akiko ; Ogawa, Yoshihiro ; Kanatsu, Kenji ; Seto, Koichi ; Yoneda, Tomoyuki ; Takeuchi, Koji. / Effect of polaprezinc on impaired healing of chronic gastric ulcers in adjuvant-induced arthritic rats - Role of insulin-like growth factors (IGF)-1. In: Medical Science Monitor. 2001 ; Vol. 7, No. 1. pp. 20-25.
@article{8c38ada6dbac42cea58bd0ca028aff6a,
title = "Effect of polaprezinc on impaired healing of chronic gastric ulcers in adjuvant-induced arthritic rats - Role of insulin-like growth factors (IGF)-1",
abstract = "Polaprezinc, N-(3-aminopropionyl)-L-histidinatozinc, has been shown to stimulate the production of insulin-like growth factor-1 (IGF-1) in mesenchymal cells, the polypeptide playing a role in the gastric epithelial wound repair. The present study was performed to examine the effect of polaprezinc on the impaired healing of chronic gastric ulcers in adjuvant-induced arthritic rats, in relation to IGF-1. Arthritis was induced in male Dark Agouti (DA) rats by a single injection of Freund's complete adjuvant (FCA), and the gastric ulcers were induced by thermal cauterization (70°C for 30 sec) 7 days after FCA injection. Omeprazole (30 mg/kg) was administered p.o. once daily, while recombinant human IGF-1 (rhIGF-1) (30 μg/kg, s.c.) or polaprezinc (3-10 mg/kg, p.o.) was administered twice daily, starting from 3 days after ulceration for 14 days. The healing of gastric ulcers was significantly delayed in arthritic rats as compared to normal rats on day 10 and 17 following ulceration. The expression of IGF-1 mRNA was markedly increased in the ulcerated mucosa, but this response was apparently attenuated in arthritic rats. Repeated administration of polaprezinc accelerated the healing of gastric ulcers in both normal and arthritic rats, in a dose-dependent manner, and this effect was more pronounced in arthritic rats. Likewise, treatment with omeprazole also significantly promoted the healing of gastric ulcers in both normal and arthritic rats. On the other hand, rhIGF-1 significantly promoted the gastric ulcer healing in arthritic rats Without any effect on that in normal rats. These results suggest that the impaired healing of chronic gastric ulcers in arthritic rats is, at least partly, accounted for by less expression of IGF-1, and the polaprezinc improves the delayed healing of gastric ulcers in arthritic rats, probably through an increase in IGF-1 production.",
author = "Shinichi Kato and Akiko Tanaka and Yoshihiro Ogawa and Kenji Kanatsu and Koichi Seto and Tomoyuki Yoneda and Koji Takeuchi",
year = "2001",
month = "2",
day = "19",
language = "English",
volume = "7",
pages = "20--25",
journal = "Medical Science Monitor",
issn = "1234-1010",
publisher = "International Scientific Literature Inc.",
number = "1",

}

TY - JOUR

T1 - Effect of polaprezinc on impaired healing of chronic gastric ulcers in adjuvant-induced arthritic rats - Role of insulin-like growth factors (IGF)-1

AU - Kato, Shinichi

AU - Tanaka, Akiko

AU - Ogawa, Yoshihiro

AU - Kanatsu, Kenji

AU - Seto, Koichi

AU - Yoneda, Tomoyuki

AU - Takeuchi, Koji

PY - 2001/2/19

Y1 - 2001/2/19

N2 - Polaprezinc, N-(3-aminopropionyl)-L-histidinatozinc, has been shown to stimulate the production of insulin-like growth factor-1 (IGF-1) in mesenchymal cells, the polypeptide playing a role in the gastric epithelial wound repair. The present study was performed to examine the effect of polaprezinc on the impaired healing of chronic gastric ulcers in adjuvant-induced arthritic rats, in relation to IGF-1. Arthritis was induced in male Dark Agouti (DA) rats by a single injection of Freund's complete adjuvant (FCA), and the gastric ulcers were induced by thermal cauterization (70°C for 30 sec) 7 days after FCA injection. Omeprazole (30 mg/kg) was administered p.o. once daily, while recombinant human IGF-1 (rhIGF-1) (30 μg/kg, s.c.) or polaprezinc (3-10 mg/kg, p.o.) was administered twice daily, starting from 3 days after ulceration for 14 days. The healing of gastric ulcers was significantly delayed in arthritic rats as compared to normal rats on day 10 and 17 following ulceration. The expression of IGF-1 mRNA was markedly increased in the ulcerated mucosa, but this response was apparently attenuated in arthritic rats. Repeated administration of polaprezinc accelerated the healing of gastric ulcers in both normal and arthritic rats, in a dose-dependent manner, and this effect was more pronounced in arthritic rats. Likewise, treatment with omeprazole also significantly promoted the healing of gastric ulcers in both normal and arthritic rats. On the other hand, rhIGF-1 significantly promoted the gastric ulcer healing in arthritic rats Without any effect on that in normal rats. These results suggest that the impaired healing of chronic gastric ulcers in arthritic rats is, at least partly, accounted for by less expression of IGF-1, and the polaprezinc improves the delayed healing of gastric ulcers in arthritic rats, probably through an increase in IGF-1 production.

AB - Polaprezinc, N-(3-aminopropionyl)-L-histidinatozinc, has been shown to stimulate the production of insulin-like growth factor-1 (IGF-1) in mesenchymal cells, the polypeptide playing a role in the gastric epithelial wound repair. The present study was performed to examine the effect of polaprezinc on the impaired healing of chronic gastric ulcers in adjuvant-induced arthritic rats, in relation to IGF-1. Arthritis was induced in male Dark Agouti (DA) rats by a single injection of Freund's complete adjuvant (FCA), and the gastric ulcers were induced by thermal cauterization (70°C for 30 sec) 7 days after FCA injection. Omeprazole (30 mg/kg) was administered p.o. once daily, while recombinant human IGF-1 (rhIGF-1) (30 μg/kg, s.c.) or polaprezinc (3-10 mg/kg, p.o.) was administered twice daily, starting from 3 days after ulceration for 14 days. The healing of gastric ulcers was significantly delayed in arthritic rats as compared to normal rats on day 10 and 17 following ulceration. The expression of IGF-1 mRNA was markedly increased in the ulcerated mucosa, but this response was apparently attenuated in arthritic rats. Repeated administration of polaprezinc accelerated the healing of gastric ulcers in both normal and arthritic rats, in a dose-dependent manner, and this effect was more pronounced in arthritic rats. Likewise, treatment with omeprazole also significantly promoted the healing of gastric ulcers in both normal and arthritic rats. On the other hand, rhIGF-1 significantly promoted the gastric ulcer healing in arthritic rats Without any effect on that in normal rats. These results suggest that the impaired healing of chronic gastric ulcers in arthritic rats is, at least partly, accounted for by less expression of IGF-1, and the polaprezinc improves the delayed healing of gastric ulcers in arthritic rats, probably through an increase in IGF-1 production.

UR - http://www.scopus.com/inward/record.url?scp=0035145118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035145118&partnerID=8YFLogxK

M3 - Article

C2 - 11208487

AN - SCOPUS:0035145118

VL - 7

SP - 20

EP - 25

JO - Medical Science Monitor

JF - Medical Science Monitor

SN - 1234-1010

IS - 1

ER -